![]() |
Volumn 182, Issue , 2015, Pages 194-199
|
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA
a a a a a a a a a a a a |
Author keywords
Coronary artery disease; Medical decision making; Perindopril; Personalized medicine
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PERINDOPRIL;
CLINICAL DECISION MAKING;
CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DEATH, SUDDEN, CARDIAC;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
EUROPE;
FEMALE;
FOLLOW UP;
HUMAN;
INCIDENCE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PERSONALIZED MEDICINE;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CLINICAL DECISION-MAKING;
CORONARY ARTERY DISEASE;
DEATH, SUDDEN, CARDIAC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
EUROPE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
PERINDOPRIL;
PRECISION MEDICINE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84948417537
PISSN: None
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2014.12.046 Document Type: Article |
Times cited : (10)
|
References (0)
|